{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:54:28Z","timestamp":1781513668151,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.compbiomed.2025.111342","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:01:21Z","timestamp":1766145681000},"page":"111342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring phytochemical inhibitors of fatty acid elongase ELOVL6 for targeted treatment of chronic myeloid leukemia: A comprehensive network-based drug discovery approach"],"prefix":"10.1016","volume":"201","author":[{"given":"Alvea","family":"Tasneem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hridoy R.","family":"Bairagya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0602-3719","authenticated-orcid":false,"given":"Ravins","family":"Dohare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10314","key":"10.1016\/j.compbiomed.2025.111342_bib1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia","volume":"398","author":"Cortes","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.111342_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111342_bib3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2015-10-674242","article-title":"Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib4","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.007","article-title":"Imatinib in chronic myeloid leukemia: an overview","volume":"6","author":"Sacha","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"S2","key":"10.1016\/j.compbiomed.2025.111342_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-015-2323-1","article-title":"Causes of resistance and treatment choices of Second- and third-line treatment in chronic myelogenous leukemia patients","volume":"94","author":"Hochhaus","year":"2015","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.compbiomed.2025.111342_bib8","first-page":"41","article-title":"Cellular and molecular state of myeloid leukemia stem cells","volume":"1143","author":"Xie","year":"2019"},{"key":"10.1016\/j.compbiomed.2025.111342_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/724360","article-title":"Emerging therapeutic strategies for targeting chronic myeloid leukemia stem cells","volume":"2013","author":"Hamad","year":"2013","journal-title":"Stem Cell. Int."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.111342_bib10","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111342_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clml.2011.10.003","article-title":"Novel combination treatments targeting chronic myeloid leukemia stem cells","volume":"12","author":"Al Baghdadi","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"23","key":"10.1016\/j.compbiomed.2025.111342_bib12","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","article-title":"The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells","volume":"123","author":"Rothe","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111342_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1878-0261.12186","article-title":"Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK \u2010 ERK and NF \u2010\u03baB pathways in a model of chronic myeloid leukemia","volume":"12","author":"Chorzalska","year":"2018","journal-title":"Mol. Oncol."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.111342_bib14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.4239.4239","article-title":"BP1001, a novel therapeutic for chronic myelogenous leukemia","volume":"128","author":"Tari Ashizawa","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.compbiomed.2025.111342_bib15","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.111342_bib16","doi-asserted-by":"crossref","first-page":"431.e1","DOI":"10.1016\/j.cmi.2017.08.018","article-title":"Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans","volume":"24","author":"Vandecasteele","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.111342_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2016.03.018","article-title":"Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem\/progenitor cell function","volume":"472","author":"Xiao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.111342_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.stem.2012.12.011","article-title":"A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition","volume":"12","author":"Goff","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/clpt.2010.91","article-title":"Network systems biology for drug discovery","volume":"88","author":"Arrell","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: a review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2024.100695","article-title":"Role of phytochemicals in cardiovascular disease management: insights into mechanisms, efficacy, and clinical application","volume":"5","author":"Alum","year":"2025","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.compbiomed.2025.111342_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1177050","article-title":"Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice","volume":"14","author":"Nisar","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111342_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2024.100113","article-title":"Phytochemical-mediated modulation of signaling pathways: a promising avenue for drug discovery","volume":"13","author":"Paul","year":"2024","journal-title":"Adv. Redox Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","article-title":"Bioavailability of phytochemicals and its enhancement by drug delivery systems","volume":"334","author":"Aqil","year":"2013","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111342_bib26","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"Imppat 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2025.111342_bib27","first-page":"93","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s43042-024-00614-2","article-title":"Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia","volume":"25","author":"Tasneem","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.111342_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111342_bib30","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2020.1991","article-title":"Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis","author":"Singh","year":"2020","journal-title":"Mol. Clin. Oncol."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.111342_bib31","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.111342_bib32","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"issue":"B","key":"10.1016\/j.compbiomed.2025.111342_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14806\/ej.17.B.265","article-title":"NOIseq: a RNA-seq differential expression method robust for sequencing depth biases","volume":"17","author":"Tarazona","year":"2012","journal-title":"EMBnet.journal"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111342_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: an online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLoS One"},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.111342_bib36","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.111342_bib37","first-page":"D271","article-title":"The RCSB protein data bank: integrative view of protein, gene and 3D structural information","volume":"45","author":"Rose","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111342_bib38","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"issue":"5016","key":"10.1016\/j.compbiomed.2025.111342_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.1853201","article-title":"A method to identify protein sequences that fold into a known three-dimensional structure","volume":"253","author":"Bowie","year":"1991","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111342_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"Web Server","key":"10.1016\/j.compbiomed.2025.111342_bib41","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-Web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.111342_bib42","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: Computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111342_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"5\u20136","key":"10.1016\/j.compbiomed.2025.111342_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"issue":"34","key":"10.1016\/j.compbiomed.2025.111342_bib45","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/S0040-4039(01)94977-9","article-title":"A new model for calculating atomic charges in molecules","volume":"19","author":"Gasteiger","year":"1978","journal-title":"Tetrahedron Lett."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111342_bib46","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/jm900391x","article-title":"Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitors","volume":"52","author":"Takahashi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.111342_bib47","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.compbiomed.2025.111342_bib48","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111342_bib49","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1021\/ja00478a008","article-title":"A method of describing the charge distribution in simple molecules","volume":"100","author":"Kollman","year":"1978","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiomed.2025.111342_bib50","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111342_bib52","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111342_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"25","key":"10.1016\/j.compbiomed.2025.111342_bib54","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111342_bib55","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"NA-NA","author":"Vanommeslaeghe","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"23","key":"10.1016\/j.compbiomed.2025.111342_bib56","doi-asserted-by":"crossref","DOI":"10.1063\/1.2121687","article-title":"A general purpose model for the condensed phases of water: TIP4P\/2005","volume":"123","author":"Abascal","year":"2005","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111342_bib57","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"20","key":"10.1016\/j.compbiomed.2025.111342_bib58","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1063\/1.1683075","article-title":"Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew","volume":"120","author":"Horn","year":"2004","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib59","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.111342_bib60","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.111342_bib61","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.111342_bib62","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh ewald: an N \u22c5log(N) method for ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111342_bib63","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1021\/acs.jctc.7b00500","article-title":"Povme 3.0: software for mapping binding pocket flexibility","volume":"13","author":"Wagner","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111342_bib64","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"16","key":"10.1016\/j.compbiomed.2025.111342_bib65","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/092986709787002817","article-title":"Topological polar surface area: a useful descriptor in 2D-QSAR","volume":"16","author":"Prasanna","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111342_bib67","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2017.170625","article-title":"The role of MicroRNA-1207-5p in colorectal cancer","volume":"63","author":"Wang","year":"2017","journal-title":"Clin. Lab."},{"key":"10.1016\/j.compbiomed.2025.111342_bib68","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.191269","article-title":"Plasma microRNA-1207-5p as a potential biomarker for diagnosis and prognosis of colorectal cancer","volume":"66","author":"Wang","year":"2020","journal-title":"Clin. Lab."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.111342_bib69","doi-asserted-by":"crossref","first-page":"32421","DOI":"10.18632\/oncotarget.8718","article-title":"miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1","volume":"7","author":"Dang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.553","article-title":"miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiomed.2025.111342_bib71","article-title":"The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma","volume":"3633","author":"Shen","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.compbiomed.2025.111342_bib72","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2018.9687","article-title":"miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to taxol treatment via the suppression of LZTS1 expression","author":"Hou","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.compbiomed.2025.111342_bib73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","article-title":"Sp1 transcription factor: a long-standing target in cancer chemotherapy","volume":"152","author":"Vizca\u00edno","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1\u20133","key":"10.1016\/j.compbiomed.2025.111342_bib74","first-page":"103","article-title":"Regulation of gene expression by SREBP and SCAP","volume":"1529","author":"Edwards","year":"2000","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111342_bib75","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.3168\/jds.2020-19292","article-title":"ELOVL6 promoter binding sites directly targeted by sterol regulatory element binding protein 1 in fatty acid synthesis of goat mammary epithelial cells","volume":"104","author":"He","year":"2021","journal-title":"J. Dairy Sci."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111342_bib76","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/hep.30953","article-title":"Hepatocyte ELOVL fatty acid elongase 6 determines ceramide acyl\u2010chain length and hepatic insulin sensitivity in mice","volume":"71","author":"Matsuzaka","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13340-020-00481-3","article-title":"Role of fatty acid elongase Elovl6 in the regulation of energy metabolism and pathophysiological significance in diabetes","volume":"12","author":"Matsuzaka","year":"2021","journal-title":"Diabetol. Int."},{"key":"10.1016\/j.compbiomed.2025.111342_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123308","article-title":"Emerging insights on the role of Elovl6 in human diseases: therapeutic challenges and opportunities","volume":"361","author":"Guo","year":"2025","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111342_bib79","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/mc.23710","article-title":"ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT\/\u0392\u2010catenin pathway","volume":"63","author":"Wang","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib80","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1038\/s41598-018-24633-3","article-title":"Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression","volume":"8","author":"Su","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3892\/ol.2016.4587","article-title":"Elovl6 is a poor prognostic predictor in breast cancer","volume":"12","author":"Feng","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12885-024-13415-y","article-title":"Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib83","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41467-025-56894-8","article-title":"Targeting ELOVL6 to disrupt C-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity","volume":"16","author":"Garc\u00eda Garc\u00eda","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.111342_bib84","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41375-023-01842-y","article-title":"The fatty acid elongase Elovl6 is crucial for hematopoietic stem cell engraftment and leukemia propagation","volume":"37","author":"Kiyoki","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.111342_bib85","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/bloodadvances.2020002578","article-title":"The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma","volume":"5","author":"Lipchick","year":"2021","journal-title":"Blood Adv."},{"issue":"37","key":"10.1016\/j.compbiomed.2025.111342_bib86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301030120","article-title":"Fatty acid elongation by ELOVL6 hampers remyelination by promoting inflammatory foam cell formation during demyelination","volume":"120","author":"Garcia Corrales","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.111342_bib87","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1021\/jm900915x","article-title":"Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors","volume":"52","author":"Mizutani","year":"2009","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.compbiomed.2025.111342_bib88","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1073\/pnas.0404600101","article-title":"Specific and differential inhibition of very-long-chain fatty acid elongases from Arabidopsis thaliana by different herbicides","volume":"101","author":"Trenkamp","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2025.111342_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172922","article-title":"Natural alkaloid and polyphenol compounds targeting lipid metabolism: treatment implications in metabolic diseases","volume":"870","author":"Cheng","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111342_bib90","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.7150\/ijbs.33837","article-title":"Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer","volume":"15","author":"Cheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111342_bib91","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/molecules28020887","article-title":"Major phytochemicals: recent advances in health benefits and extraction method","volume":"28","author":"Kumar","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.55640\/ijmsdh-10-01-03","article-title":"Phytochemicals: a new arsenal in drug discovery","volume":"10","author":"Ahmed","year":"2024","journal-title":"Int. J. Med. Sci. Dent. Health"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.109.150854","volume":"330","author":"Shimamura","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111342_bib94","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s42004-025-01472-8","article-title":"A quantitative analysis of ligand binding at the protein-lipid bilayer interface","volume":"8","author":"Barkdull","year":"2025","journal-title":"Commun. Chem."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525016968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525016968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:16:18Z","timestamp":1781511378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525016968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":94,"alternative-id":["S0010482525016968"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111342","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring phytochemical inhibitors of fatty acid elongase ELOVL6 for targeted treatment of chronic myeloid leukemia: A comprehensive network-based drug discovery approach","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111342"}}